FDA Approves Lamzede (velmanase alfa-tycv) for the Treatment of Alpha-Mannosidosis
First and only enzyme replacement therapy for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients
Ultra-rare progressive disease presents with wide range of...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Pediatrics